Patents-Review.com
ClassID:

116837 ⎘

C12Y304/21034 - CPC Classification

Classification description:

Hydrolases acting on peptide bonds, i.e. peptidases (3.4); Serine endopeptidases (3.4.21) Plasma kallikrein (3.4.21.34)

Recent Application in this class:
#1
20260151507
2026-06-04

COMPOSITIONS AND METHODS FOR GENOME EDITING

 #2
20250145999
2025-05-08

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF PREKALLIKREIN (PKK) PROTEIN

 #3
20250115915
2025-04-10

PREKALLIKREIN-MODULATING COMPOSITIONS AND METHODS OF USE THEREOF

 #4
20240318183
2024-09-26

MODULATION OF PREKALLIKREIN (PKK) EXPRESSION

 #5
20230081547
2023-03-16

NON-HUMAN ANIMALS COMPRISING A HUMANIZED KLKB1 LOCUS AND METHODS OF USE

 #6
20220315929
2022-10-06

NUCLEIC ACID, PHARMACEUTICAL COMPOSITION AND CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF

 #7
20220291232
2022-09-15

ASSAYS FOR DETERMINING PLASMA KALLIKREIN SYSTEM BIOMARKERS

 #8
20220218639
2022-07-14

TUNEABLE DELIVERY OF NANOPARTICLE BOUND ACTIVE PLASMIN FOR THE TREATMENT OF THROMBOSIS

 #9
20220170023
2022-06-02

Modulation of prekallikrein (PKK) expression

 #10
20200261386
2020-08-20

Tuneable delivery of nanoparticle bound active plasmin for the treatment of thrombosis

 #11
20190233827
2019-08-01

Modulation of prekallikrein (PKK) expression

 #12
20180143205
2018-05-24

BIOMARKERS FOR PREDICTING DEGREE OF WEIGHT LOSS IN FEMALE SUBJECTS

 #13
20170314026
2017-11-02

Modulation of prekallikrein (PKK) expression

 #14
20170189362
2017-07-06

Tuneable delivery of nanoparticle bound active plasmin for the treatment of thrombosis

 #15
20160252527
2016-09-01

Assays for determining plasma kallikrein system biomarkers

 #16
20140213631
2014-07-31

Methods for modulating kallikrein (KLKB1) expression

 #17
20130028843
2013-01-31

KALLIKREIN 7 MODULATORS

 #18
20100256144
2010-10-07

Kallikrein 7 modulators

 #19
20070178114
2007-08-02

Kallikrein gene

 #20
20050227939
2005-10-13

Modulation of kallikrein 6 expression